Tag Archives: hospitalisations
August 2024 Br J Cardiol 2024;31:101–5 doi:10.5837/bjc.2024.032
Rehospitalisation rates of heart failure patients treated with SGLT2 inhibitors as an inpatient versus post-discharge
Roy Bo Wang, Michelle Che Ting Yick, Martin Thomas, Simon Woldman, Ceri Davies, Sveeta Badiani, Debashish Das, Paul Wright, Sotiris Antoniou, Christopher Primus, Francesco Papalia, Angela Gallagher, Shanti Velmurugan
Introduction Heart failure with reduced ejection fraction (HFrEF) is a significant healthcare burden internationally, with an age-standardised prevalence of approximately 3.8% in women and 4.6% in men, and an estimated five-year mortality rate of 43%.1,2 Hospitalisations for heart failure exacerbations represent a major financial challenge to health services, and such patients have a higher risk of readmission and mortality.3 Previously, the DAPA-HF (Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction) trial demonstrated that dapagliflozin significantly reduces the risk of worsening heart failure and cardiovascular deat
February 2016 Br J Cardiol 2016;23:(1) doi:10.5837/bjc.2016.004
Delivering early rehabilitation after an exacerbation of heart failure: is it feasible? A short report
Linzy Houchen-Wolloff, Amye Watt, Sally Schreder, Sally Singh
(more…)
For healthcare professionals only
